ZY-19489
ZY-19489 is a promising antimalarial small molecule candidate with potential as a single-dose therapeutic against both Plasmodium falciparum and P. vivax, recognized by the FDA with orphan drug status. It is utilized in malaria research for investigating its mechanism of action and efficacy in both in vitro parasite inhibition assays and in vivo animal models of infection.
Product Specifications
CAS Number
1821293-40-6
Product Name Alternative
2,4Pyrimidinediamine, N2 (4cyclopropyl5fluoro6methyl2pyridinyl) 5[ (3R) 3,4dimethyl1piperazinyl]N4 (1,5dimethyl1Hpyrazol3yl), P. falciparum, ZY 19489, ZY19489, ZY-19489
Field of Research
Infectious Disease & Virology
Purity
99.84% (May vary between batches)
Solubility
DMSO:4.66 mg/mL (10.01 mM)
Smiles
N (C=1C (=CN=C (NC2=CC (=C (F) C (C) =N2) C3CC3) N1) N4C[C@@H] (C) N (C) CC4) C=5C=C (C) N (C) N5
Molecular Formula
C24H32FN9
Molecular Weight
465.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
130063-ML490 100 µL
MYLC2PL (MYL10, Myosin Regulatory Light Chain 10, Myosin Light Chain 2, Lymphocyte-specific, Precursor Lymphocyte-specific Regulatory Light Chain, PLRLC, MGC3479) (MaxLight 490)
Sign In for Pricing
View Details 
18219061 1.0 µg DNA
DIAPH2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details